ARKK Holdings of ILMN
Illumina
Illumina, Inc. is a biotechnology company that specializes in the development and manufacturing of advanced sequencing and array-based solutions for genetic analysis. It generates revenue primarily by selling its sequencing systems, consumables, and services to research institutions, healthcare facilities, and pharmaceutical companies for applications in genomics and personalized medicine.
Trades of ILMN in ARKK
The ten most recent trades of Illumina in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 14, 2025 | Buy | $1,231,048 | 1.30% | 0.02% |
| Jan 10, 2025 | Buy | $1,549,002 | 1.78% | 0.02% |
| Jan 08, 2025 | Buy | $945,417 | 1.08% | 0.01% |
| Jan 07, 2025 | Buy | $608,503 | 0.69% | 0.01% |
| Jan 06, 2025 | Buy | $15,361,781 | 21.44% | 0.24% |
| Dec 31, 2024 | Buy | $10,545,029 | 17.83% | 0.16% |
| Nov 27, 2024 | Buy | $1,321,072 | 2.12% | 0.02% |
| Nov 26, 2024 | Buy | $7,159,704 | 13.23% | 0.11% |
| Nov 25, 2024 | Buy | $4,667,786 | 9.37% | 0.07% |
| Nov 11, 2024 | Buy | $5,903,201 | 12.63% | 0.09% |